Experimental gene therapy targets rare blindness in japanese patients
NCT ID NCT05926583
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 30 times
Summary
This study tests a gene therapy for a rare inherited eye disease called X-linked retinitis pigmentosa, which causes gradual vision loss. The treatment delivers a working gene to the retina using a harmless virus. The study involves 4 Japanese participants aged 5 or older and focuses on safety and whether it can slow vision decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Hospital Organization Tokyo Medical Center
Meguro-ku, 1528902, Japan
Conditions
Explore the condition pages connected to this study.